SYRS

Syros Pharmaceuticals, Inc. Common Stock

Delisted

SYRS was delisted on the 19th of March, 2025.

106 hedge funds and large institutions have $475M invested in Syros Pharmaceuticals, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 44 increasing their positions, 29 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
106
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.32M
Puts
$3.17M
Net Calls
Net Calls Change

Top Sellers

1 -$9.95M
2 -$4.14M
3 -$1.83M
4
Millennium Management
Millennium Management
New York
-$1.58M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$1.47M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$67.4M
2
$57.7M
3
$43.3M
4
$38.6M
5
$37.7M
6
$31.2M
7
$23.5M
8
$22M
9
$20.4M
10
$14.8M
11
$13.7M
12
$11.7M
13
$7.67M
14
$7.48M
15
$6.73M
16
$6.23M
17
$5.95M
18
$5.22M
19
$5.16M
20
$4.97M
21
$4.76M
22
$3.89M
23
$2.8M
24
$2.72M
25
$2.63M